PT1664033E - Análogos de 9,1o-a,a-oh-taxanos e processos para sua produção - Google Patents

Análogos de 9,1o-a,a-oh-taxanos e processos para sua produção

Info

Publication number
PT1664033E
PT1664033E PT04789167T PT04789167T PT1664033E PT 1664033 E PT1664033 E PT 1664033E PT 04789167 T PT04789167 T PT 04789167T PT 04789167 T PT04789167 T PT 04789167T PT 1664033 E PT1664033 E PT 1664033E
Authority
PT
Portugal
Prior art keywords
alpha
group
hydroxyl
methods
taxane analogs
Prior art date
Application number
PT04789167T
Other languages
English (en)
Inventor
James D Mcchesney
James Ferrara
Jan Zygmut
Original Assignee
Tapestry Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tapestry Pharmaceuticals Inc filed Critical Tapestry Pharmaceuticals Inc
Publication of PT1664033E publication Critical patent/PT1664033E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • A61P35/02Antineoplastic agents specific for leukemia
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D305/00Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms
    • C07D305/14Heterocyclic compounds containing four-membered rings having one oxygen atom as the only ring hetero atoms condensed with carbocyclic rings or ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D409/00Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/12Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Epoxy Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PT04789167T 2003-09-25 2004-09-27 Análogos de 9,1o-a,a-oh-taxanos e processos para sua produção PT1664033E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US50668003P 2003-09-25 2003-09-25

Publications (1)

Publication Number Publication Date
PT1664033E true PT1664033E (pt) 2008-01-17

Family

ID=34393186

Family Applications (1)

Application Number Title Priority Date Filing Date
PT04789167T PT1664033E (pt) 2003-09-25 2004-09-27 Análogos de 9,1o-a,a-oh-taxanos e processos para sua produção

Country Status (14)

Country Link
US (8) US7745650B2 (pt)
EP (2) EP1664033B1 (pt)
JP (5) JP4874102B2 (pt)
CN (1) CN1886400A (pt)
AT (1) ATE377593T1 (pt)
AU (1) AU2004275881A1 (pt)
CA (1) CA2539975C (pt)
DE (1) DE602004009943T2 (pt)
DK (1) DK1664033T3 (pt)
ES (1) ES2295937T3 (pt)
HR (1) HRP20080057T3 (pt)
PL (1) PL1664033T3 (pt)
PT (1) PT1664033E (pt)
WO (1) WO2005030150A2 (pt)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1664033B1 (en) 2003-09-25 2007-11-07 Tapestry Pharmaceuticals, Inc. 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof
CN101535492A (zh) 2005-02-11 2009-09-16 南加州大学 表达含有二硫键的蛋白质的方法
AU2006331674A1 (en) * 2005-12-21 2007-07-05 Tapestry Pharmaceuticals, Inc. Processes for taxane derivatives and intermediates useful therein
WO2007073383A1 (en) * 2005-12-21 2007-06-28 Tapestry Pharmaceuticals, Inc. Novel compounds and methods for forming taxanes and using the same
US20070225510A1 (en) * 2006-03-27 2007-09-27 Henri John T Convergent Process for the Synthesis of Taxane Derivatives
WO2007130501A2 (en) * 2006-05-01 2007-11-15 University Of Southern California Combination therapy for treatment of cancer
WO2007143839A1 (en) * 2006-06-12 2007-12-21 6570763 Canada Inc. Semi-synthetic route for the preparation of paclitaxel, docetaxel and 10-deacetylbaccatin iii from 9-dihydro-13-acetylbaccatin iii
US7847111B2 (en) 2006-06-19 2010-12-07 Canada Inc. Semi-synthetic route for the preparation of paclitaxel, docetaxel, and 10-deacetylbaccatin III from 9-dihydro-13-acetylbaccatin III
US11786504B2 (en) 2006-09-28 2023-10-17 Tapestry Pharmaceuticals, Inc. Taxane analogs for the treatment of brain cancer
WO2008106621A1 (en) 2007-02-28 2008-09-04 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
US11873308B2 (en) 2006-11-06 2024-01-16 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
WO2008121476A1 (en) * 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
US20080207743A1 (en) * 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment
WO2010056901A2 (en) 2008-11-13 2010-05-20 University Of Southern California Method of expressing proteins with disulfide bridges with enhanced yields and activity
US9227983B2 (en) 2011-04-07 2016-01-05 Arbor Therapeutics, LLC Taxane and abeo-taxane analogs
AU2012364858A1 (en) * 2011-04-07 2013-11-21 Arbor Therapeutics, LLC Taxane and abeo-taxane analogs
JP5621071B2 (ja) * 2011-06-06 2014-11-05 アーバー・セラピューティクス・リミテッド・ライアビリティ・カンパニーArbor Therapeutics,LLC 癌化学療法薬の酸に不安定で親油性のプロドラッグ

Family Cites Families (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX9102128A (es) * 1990-11-23 1992-07-08 Rhone Poulenc Rorer Sa Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene
US6794523B2 (en) 1991-09-23 2004-09-21 Florida State University Taxanes having t-butoxycarbonyl substituted side-chains and pharmaceutical compositions containing them
WO1993021173A1 (en) * 1992-04-17 1993-10-28 Abbott Laboratories Taxol derivatives
FR2697019B1 (fr) 1992-10-15 1994-11-25 Rhone Poulenc Rorer Sa Nouveaux dérivés du taxane, leur préparation et les compositions pharmaceutiques qui les contiennent.
DK0668762T3 (da) * 1992-11-13 2004-01-05 Univ Florida State Isobytenyl-substituerede taxaner og farmaceutiske præparater deraf
EP0688212B1 (en) * 1993-03-05 2002-06-12 Florida State University C9 taxane derivatives and pharmaceutical compositions containing them
US6710191B2 (en) * 1993-03-05 2004-03-23 Florida State University 9β-hydroxytetracyclic taxanes
JP3892481B2 (ja) 1993-03-05 2007-03-14 フロリダ・ステート・ユニバーシティー 9−デスオキソタキサンの製法
DE69434373T2 (de) 1993-03-22 2006-03-09 Florida State University, Tallahassee Beta-laktame zur Herstellung von Taxanen mit Furyl oder Thienyl substituierter Seitenkette
FR2707293A1 (fr) 1993-07-08 1995-01-13 Rhone Poulenc Rorer Sa Nouveaux taxoides, leur préparation et les compositions pharmaceutiques qui les contiennent.
FR2715846A1 (fr) * 1994-02-07 1995-08-11 Rhone Poulenc Rorer Sa Nouvelle composition pharmceutique à base de taxoïdes.
IT1275936B1 (it) 1995-03-17 1997-10-24 Indena Spa Derivati della 10-deacetilbaccatina iii e della 10-deacetil-14b- idrossibaccatina iii loro metodo di preparazione e formulazioni
US5635531A (en) * 1996-07-08 1997-06-03 Bristol-Myers Squibb Company 3'-aminocarbonyloxy paclitaxels
US5739359A (en) 1997-01-24 1998-04-14 Virginia Tech Intellectual Properties, Inc. Methods for preparing 1-deoxy paclitaxels
US6048990A (en) * 1998-05-01 2000-04-11 Napro Biotherapeutics, Inc. Method for selective acylation of C-2'-O-protected-10-hydroxy-taxol at the C-10 position
AR030188A1 (es) * 2000-02-02 2003-08-13 Univ Florida State Res Found Compuestos de taxano sustituidos con esteres en el c7; composiciones farmaceuticas que los contienen y proceso para tratar un sujeto mamifero que sufre de una condicion que responde a los taxanos
HUP0200750A3 (en) * 2000-02-02 2005-02-28 Univ Florida State Res Found C10 heterosubstituted acetate taxanes as antitumor agents and pharmaceutical compositions containing them and their use
JP2004528309A (ja) 2001-03-23 2004-09-16 ナプロ バイオセラピューティクス,インコーポレイテッド 癌治療用分子複合体
CA2354471A1 (en) 2001-07-31 2003-01-31 Florida State University Research Foundation, Inc. C10 ester substituted taxanes
RS52904A (en) 2001-12-20 2006-12-15 Bristol-Myers Squib Company Pharmaceutical compositions of orally active taxane derivatives having enhanced bioavailability
US6898834B1 (en) * 2003-03-03 2005-05-31 Westbridge Pty Ltd Barrel stave reclaim
EP1894921A3 (en) 2003-09-25 2008-03-12 Tapestry Pharmaceuticals, Inc. 9, 10-Alpha, Alpha-Oh-Taxane analogs and methods for production thereof
EP1664033B1 (en) * 2003-09-25 2007-11-07 Tapestry Pharmaceuticals, Inc. 9,10-alpha,alpha-oh-taxane analogs and methods for production the reof
WO2006124737A2 (en) 2005-05-12 2006-11-23 Tapestry Pharmaceuticals, Inc. Molecular constructs suitable for targeted conjugates
WO2007073383A1 (en) 2005-12-21 2007-06-28 Tapestry Pharmaceuticals, Inc. Novel compounds and methods for forming taxanes and using the same
AU2006331674A1 (en) 2005-12-21 2007-07-05 Tapestry Pharmaceuticals, Inc. Processes for taxane derivatives and intermediates useful therein
US20070225510A1 (en) 2006-03-27 2007-09-27 Henri John T Convergent Process for the Synthesis of Taxane Derivatives
WO2008106621A1 (en) 2007-02-28 2008-09-04 Tapestry Pharmaceuticals, Inc Taxane analogs for the treatment of brain cancer
WO2008121476A1 (en) 2007-03-28 2008-10-09 Tapestry Pharmaceuticals, Inc. Biologically active taxane analogs and methods of treatment by oral administration
US20080207743A1 (en) 2007-02-28 2008-08-28 Rodger Lamb Biologically Active Taxane Analogs and Methods of Treatment

Also Published As

Publication number Publication date
JP5629632B2 (ja) 2014-11-26
US20120077871A1 (en) 2012-03-29
US7745650B2 (en) 2010-06-29
CN1886400A (zh) 2006-12-27
US20180125811A1 (en) 2018-05-10
JP5525394B2 (ja) 2014-06-18
DE602004009943D1 (de) 2007-12-20
JP6216417B2 (ja) 2017-10-18
JP4874102B2 (ja) 2012-02-15
US20050148657A1 (en) 2005-07-07
JP2014196345A (ja) 2014-10-16
US8962870B2 (en) 2015-02-24
EP1785416A2 (en) 2007-05-16
AU2004275881A1 (en) 2005-04-07
US20190142784A1 (en) 2019-05-16
US20150133536A1 (en) 2015-05-14
HRP20080057T3 (en) 2008-02-29
EP1664033A2 (en) 2006-06-07
DK1664033T3 (da) 2008-03-25
ATE377593T1 (de) 2007-11-15
WO2005030150A2 (en) 2005-04-07
CA2539975C (en) 2012-11-20
US9820962B2 (en) 2017-11-21
WO2005030150A3 (en) 2005-07-14
US9402824B2 (en) 2016-08-02
JP2011137045A (ja) 2011-07-14
PL1664033T3 (pl) 2008-04-30
US10238621B2 (en) 2019-03-26
EP1785416A3 (en) 2007-05-30
JP2016180006A (ja) 2016-10-13
ES2295937T3 (es) 2008-04-16
DE602004009943T2 (de) 2008-08-28
JP2007506792A (ja) 2007-03-22
US20100324128A1 (en) 2010-12-23
CA2539975A1 (en) 2005-04-07
JP6106634B2 (ja) 2017-04-05
EP1664033A4 (en) 2006-09-13
US7879904B2 (en) 2011-02-01
US20160331718A1 (en) 2016-11-17
EP1664033B1 (en) 2007-11-07
US10639293B2 (en) 2020-05-05
JP2011012070A (ja) 2011-01-20
US20200237708A1 (en) 2020-07-30

Similar Documents

Publication Publication Date Title
HRP20080057T3 (en) 9,10-alpha,alpha-oh-taxane analogs and methods for production thereof
EP1277752A4 (en) PROCESS FOR PREPARING OPTIC-ACTIVE SULFOXIDE DERIVATIVES
ATE527270T1 (de) Herstellung von organosilanestern
WO2004084812A3 (en) Tamandarin analogs and fragments thereof and methods of making and using
ATE372343T1 (de) Verfahren zur herstellung von 6-alkoxy-(6h)- dibenz(c,e)(1,2)-oxaphosphorinen
TW200517376A (en) 4-(aminomethyl)-piperidine benzamides as 5HT4-antagonists
GEP20074256B (en) Novel benzothiadiazine, process for their preparation and pharmaceutical compositions containing
EP1810968A3 (en) 9, 10-a, a-OH-taxane analogs and methods for production thereof
BRPI0712192A2 (pt) Composição de poliolefina, mistura-padrão processo para produção de um artigo, artigo, uso de uma composição de poliolefina e uso de um composto contendo silício
ATE372332T1 (de) Verfahren zur herstellung von zwischenverbindungen in der herstellung von discodermolid und discodermolid-analoga
ATE523198T1 (de) Pyrroloä2,3-düpyrimidine zur behandlung von krebs durch mitosehemmung
DE602004014769D1 (de) Reaktive flammschutzmittel und flammgeschützte harzprodukte
DE69616719T2 (de) Verfahren zur herstellung von taxol und seiner derivate
EP1022269A3 (en) Sulfonium salts and method of synthesis
NZ335105A (en) Process for alkylating hindered sulfonamides
RS20060157A (en) Method for the manufacture of thip
TW200720282A (en) Novel organosilicon compound and process for producing the same
ATE553081T1 (de) Verfahren zur herstellung einer bakteriziden pyridinverbindung, und bakterizide pyridinverbindung
DE602004020050D1 (de) Verfahren zur herstellung substituierter imidazolderivate und in dem verfahren verwendete zwischenprodukte
IL166696A0 (en) A process for producing y-ketoacetal compounds
PT102935B (pt)
ES2285967T1 (es) Procedimiento para elaborar derivados de taxano.
HK1114084A1 (en) Method for producing thiocarbamate derivative
EP1614684B8 (en) Diamine derivative, production process, and antioxidizing drug
ATE506349T1 (de) Verfahren zur herstellung von 7-chinolinyl-3,5- dihydroxyhept-6-enoat